L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.2 Billion EUR | 35.23% |
| 2022 | 1.62 Billion EUR | -3.84% |
| 2021 | 1.69 Billion EUR | 39.12% |
| 2020 | 1.21 Billion EUR | -1.22% |
| 2019 | 1.23 Billion EUR | 40.15% |
| 2018 | 879.77 Million EUR | 141.9% |
| 2017 | 363.68 Million EUR | 12.59% |
| 2016 | 323.01 Million EUR | -2.94% |
| 2015 | 332.78 Million EUR | -4.69% |
| 2014 | 349.16 Million EUR | 11.85% |
| 2013 | 312.16 Million EUR | 4.5% |
| 2012 | 298.72 Million EUR | 17.05% |
| 2011 | 255.21 Million EUR | 15.69% |
| 2010 | 220.59 Million EUR | -19.87% |
| 2009 | 275.31 Million EUR | 25.2% |
| 2008 | 219.9 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 1.98 Billion EUR | 21.81% |
| 2023 Q3 | 2.2 Billion EUR | 11.02% |
| 2023 Q4 | 2.2 Billion EUR | 0.0% |
| 2023 Q2 | 1.98 Billion EUR | 0.0% |
| 2023 FY | 2.2 Billion EUR | 35.23% |
| 2022 Q1 | 1.71 Billion EUR | 1.36% |
| 2022 FY | 1.62 Billion EUR | -3.84% |
| 2022 Q4 | 1.62 Billion EUR | 0.0% |
| 2022 Q3 | 1.62 Billion EUR | -5.13% |
| 2022 Q2 | 1.71 Billion EUR | 0.0% |
| 2021 Q4 | 1.69 Billion EUR | 0.0% |
| 2021 Q3 | 1.69 Billion EUR | 47.01% |
| 2021 FY | 1.69 Billion EUR | 39.12% |
| 2021 Q2 | 1.15 Billion EUR | 0.0% |
| 2021 Q1 | 1.15 Billion EUR | -5.37% |
| 2020 Q4 | 1.21 Billion EUR | 0.0% |
| 2020 Q2 | 1.32 Billion EUR | 0.0% |
| 2020 Q3 | 1.21 Billion EUR | -8.14% |
| 2020 FY | 1.21 Billion EUR | -1.22% |
| 2020 Q1 | 1.32 Billion EUR | 7.53% |
| 2019 Q2 | 1.3 Billion EUR | 0.0% |
| 2019 Q4 | 1.23 Billion EUR | 0.0% |
| 2019 FY | 1.23 Billion EUR | 40.15% |
| 2019 Q1 | 1.3 Billion EUR | 48.56% |
| 2019 Q3 | 1.23 Billion EUR | -5.66% |
| 2018 Q3 | 907.86 Million EUR | 130.65% |
| 2018 FY | 879.77 Million EUR | 141.9% |
| 2018 Q4 | 879.77 Million EUR | -3.09% |
| 2018 Q2 | 393.6 Million EUR | 0.0% |
| 2018 Q1 | 393.6 Million EUR | 8.23% |
| 2017 Q2 | 378.55 Million EUR | 0.0% |
| 2017 Q1 | 378.55 Million EUR | 17.19% |
| 2017 FY | 363.68 Million EUR | 12.59% |
| 2017 Q3 | 363.68 Million EUR | -3.93% |
| 2017 Q4 | 363.68 Million EUR | 0.0% |
| 2016 Q3 | 323.01 Million EUR | -10.35% |
| 2016 FY | 323.01 Million EUR | -2.94% |
| 2016 Q1 | 360.29 Million EUR | 8.27% |
| 2016 Q2 | 360.29 Million EUR | 0.0% |
| 2016 Q4 | 323.01 Million EUR | 0.0% |
| 2015 Q2 | 434.22 Million EUR | 0.0% |
| 2015 Q3 | 332.78 Million EUR | -23.36% |
| 2015 Q4 | 332.78 Million EUR | 0.0% |
| 2015 FY | 332.78 Million EUR | -4.69% |
| 2015 Q1 | 434.22 Million EUR | 24.36% |
| 2014 Q2 | 331.38 Million EUR | 0.0% |
| 2014 FY | 349.16 Million EUR | 11.85% |
| 2014 Q4 | 349.16 Million EUR | 0.0% |
| 2014 Q3 | 349.16 Million EUR | 5.37% |
| 2014 Q1 | 331.38 Million EUR | 6.16% |
| 2013 Q4 | 312.16 Million EUR | 0.0% |
| 2013 Q2 | 344.05 Million EUR | 0.0% |
| 2013 Q1 | 344.05 Million EUR | 15.17% |
| 2013 FY | 312.16 Million EUR | 4.5% |
| 2013 Q3 | 312.16 Million EUR | -9.27% |
| 2012 FY | 298.72 Million EUR | 17.05% |
| 2012 Q1 | 335.23 Million EUR | 31.36% |
| 2012 Q3 | 298.72 Million EUR | -10.89% |
| 2012 Q4 | 298.72 Million EUR | 0.0% |
| 2012 Q2 | 335.23 Million EUR | 0.0% |
| 2011 Q4 | 255.21 Million EUR | 0.0% |
| 2011 FY | 255.21 Million EUR | 15.69% |
| 2011 Q2 | 269.3 Million EUR | 0.0% |
| 2010 Q2 | 236.07 Million EUR | 0.0% |
| 2010 Q4 | 220.59 Million EUR | 0.0% |
| 2010 FY | 220.59 Million EUR | -19.87% |
| 2009 Q4 | 275.31 Million EUR | 0.0% |
| 2009 FY | 275.31 Million EUR | 25.2% |
| 2008 FY | 219.9 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -615.293% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | -107.177% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -1919.709% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -1144.162% |
| Huasheng International Holding Limited | 675.58 Million HKD | -226.167% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -3465.283% |
| Evergreen Products Group Limited | 786.46 Million HKD | -180.18% |
| EC Healthcare | 2.97 Billion HKD | 25.814% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | -185.426% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | -36.202% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -1179.095% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -5042.531% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -1115.08% |